Joel Farley, PhD

Professor
University of Minnesota College of Pharmacy

Poster(s):

• (271) Discontinuation of long-acting injectable versus oral antipsychotics in US patients with schizophrenia: a new-user survival analysis
  Wednesday, October 29, 2025